Adrenocortical carcinoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{AAM}} | {{CMG}} {{AE}} {{AAM}} | ||
==Overview== | ==Overview== | ||
The most potent risk factors in the development of adrenocortical cancer are [[TP53| TP53 mutation]], [[Beckwith-Wiedemann syndrome]] and [[Carney complex]].<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/adrenocortical/patient/adrenocortical-treatment-pdq#section/_1</ref> | The most potent risk factors in the development of adrenocortical cancer are [[TP53| TP53 mutation]], [[Beckwith-Wiedemann syndrome]] and [[Carney complex]].<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/adrenocortical/patient/adrenocortical-treatment-pdq#section/_1</ref> | ||
==Common Risk Factors== | ==Common Risk Factors== | ||
Revision as of 19:11, 26 August 2015
|
Adrenocortical carcinoma Microchapters |
|
Differentiating Adrenocortical carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Study |
|
Adrenocortical carcinoma risk factors On the Web |
|
American Roentgen Ray Society Images of Adrenocortical carcinoma risk factors |
|
Risk calculators and risk factors for Adrenocortical carcinoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
The most potent risk factors in the development of adrenocortical cancer are TP53 mutation, Beckwith-Wiedemann syndrome and Carney complex.[1]
Common Risk Factors
Families with Li-Fraumeni syndrome (TP53 mutation), Beckwith-Wiedemann syndrome and Carney complex have increased risk for adrenocortical cancer.
References
- ↑ National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/adrenocortical/patient/adrenocortical-treatment-pdq#section/_1